PuraPharm Corp. Ltd. ( (HK:1498) ) just unveiled an update.
PuraPharm Corporation Limited has announced the effective date for its capital reduction and subdivision, following a court order confirming the capital reduction. The registration of the court order with the Cayman Islands Registrar of Companies has fulfilled all conditions for the implementation. Consequently, the effective date for the capital reduction and subdivision is set for March 13, 2025, with new ordinary shares commencing trading on the same day. Shareholders can exchange their existing share certificates for new ones between March 13 and April 24, 2025, at no cost.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It is involved in the production and distribution of herbal medicines and related products, focusing on traditional Chinese medicine.
Average Trading Volume: 88,740
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$217.2M
For a thorough assessment of 1498 stock, go to TipRanks’ Stock Analysis page.